N-Methanocarbathymidine
Alternative Names: N-MCTLatest Information Update: 28 May 2020
Price :
$50 *
At a glance
- Originator N&N Pharmaceuticals
- Class
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Herpes simplex virus infections; Herpes zoster; Poxvirus infections
Most Recent Events
- 28 May 2020 No recent reports of development identified for preclinical development in Herpes-simplex-virus-infections in USA (PO)
- 28 May 2020 No recent reports of development identified for preclinical development in Poxvirus-infections in USA (PO)
- 28 May 2019 No recent reports of development identified for phase-I development in Herpes-zoster(In volunteers) in USA (PO)